Despite a marijuana boom amid the pandemic, some Canadian cannabis stocks have failed to generate profits. There are many reasons for this, including fewer legal stores than anticipated, a smaller market than that of the U.S., black-market sales eating into revenue, and regulatory holdups. Popular Canadian players including Aurora Cannabis (NASDAQ: ACB) and Canopy Growth (NASDAQ: CGC) have been struggling for a while now to achieve positive earnings before interest, tax, depreciation, and amortization (EBITDA).
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting